GenFleet Therapeutics IPO Lockup - A Minor Prelude to a Much Bigger Release
GenFleet Therapeutics (GFT) raised around US$240m in its Hong Kong IPO in September 2025. The lockup on its cornerstone investors is set to expire...
291 Views
Primer: GenFleet Therapeutics (GENFL12 HK) - Sep 2025
GenFleet Therapeutics is a clinical-stage biopharmaceutical company with a strong focus on developing novel therapies in oncology and...
68 Views
Pre-IPO GenFleet Therapeutics (PHIP Updates) - Some Points Worth the Attention
GenFleet's IPO debut is eye-catching.Besides continuous enthusiasm for Biotech IPO, the endorsement of famous cornerstone investors brings great...
809 Views
Genfleet (劲方医药) IPO: Trading Update
​Genfleet raises $233m in global offering and is set to list on HKSE on Sept 18. We provides an update prior to its trading debut.
411 Views
APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia
Wuxi XDC inked deal with Akari Therapeutics. Xuanzhu Bio entered licensing deal with Boston Oncology. Shionogi secured $119M BARDA contract for...
304 Views